| Product Name | MF | CAS | Details |
|---|
| RAPTA-C | C16H23Cl2N3PRu | 372948-28-2 | Details |
| Orphan GPCR SP9155 agonist P550 (mouse, rat) acetate | Details |
| Ras Inhibitory Peptide acetate | Details |
| Ro 41-5253 | C28H36O5S | 144092-31-9 | Details |
| Pomalidomide-PEG4-Ph-NH2, 10 mM in DMSO | C27H32N4O8 | 1818885-63-0 | Details |
| Moiramide B | C25H31N3O5 | 155233-31-1 | Details |
| SDZ 224-015 | C30H35Cl2N3O9 | 161511-45-1 | Details |
| RS 100329 hydrochloride | C20H26ClF3N4O3 | 1215654-26-4 | Details |
| PD 407824 | C20H12N2O3 | 622864-54-4 | Details |
| N-Boc-4-hydroxy-L-proline methyl ester | C11H19NO5 | 102195-79-9 | Details |
| MK-0773, 10 mM in DMSO | C27H34FN5O2 | 606101-58-0 | Details |
| p53-Mdm2 inhibitor 4 | C23H20FN3O3 | 350678-63-6 | Details |
| NDSB-211, 10 mM in DMSO | C7H19NO5S | 38880-58-9 | Details |
| Neuromedin U (rat) acetate | Details |
| Pteroside B | C20H28O7 | Details |
| S3I-201, 10 mM in DMSO | C16H15NO7S | 501919-59-1 | Details |
| MK-0674 | C26H27F6N3O2 | 887781-62-6 | Details |
| Ochratoxin B | C20H19NO6 | 4825-86-9 | Details |
| Plogosertib | C34H48N8O3 | 1137212-79-3 | Details |
| Quilseconazole Formic acid(1340593-70-5 Free base) | Details |
| Schistoflrfamide acetate | Details |
| Quilseconazole Formic acid(1340593-70-5 Free base), 10 mM in DMSO | Details |
| MJ 15 | C23H17Cl3N4O | 944154-76-1 | Details |
| PF-04957325, 10 mM in DMSO | C14H15F3N8OS | 1305115-80-3 | Details |
| Pseudane IX | C18H25NO | 55396-45-7 | Details |
| NFAT Inhibitor-2, 10 mM in DMSO | C22H20F2N2O4S | 422546-87-0 | Details |
| Protein kinase G inhibitor-2, 10 mM in DMSO | C14H18N2O2S | 612829-80-8 | Details |
| PLH1215 | 1332084-64-6 | Details |
| OPC18750 HCl, 10 mM in DMSO | C20H22N2O4.ClH | 145364-90-5 | Details |
| NSC 122393 | C20 H8 Br4 O5 | 73654-97-4 | Details |
| Povorcitinib phosphate, 10 mM in DMSO | C23H25F5N7O5P | 1637677-33-8 | Details |
| SF-22 (NPY Y2 antagonist) | C28H26N2O3S | 824981-55-7 | Details |
| RORγ inverse agonist 1 | C22H20F3N3O3S | 529500-72-9 | Details |
| PROT-IN-1, 10 mM in DMSO | C23H22N2O | 329935-45-7 | Details |
| PI3K-IN-46, 10 mM in DMSO | C13H9N3OS | 304645-61-2 | Details |
| Pranazepide | C26H19FN4O2 | 150408-73-4 | Details |
| MRE3008F20 | C21H20N8O3 | 252979-43-4 | Details |
| PAPA NONOate | C6H16N4O2 | 146672-58-4 | Details |
| MIV-247 | C17H24F3N3O4 | 1352817-76-5 | Details |
| N-Demethylricinine, 10 mM in DMSO | C7H6N2O2 | 21642-98-8 | Details |
| Prolyl-4-hydroxylase Inhibitor 11 | C12H8N2O4 | 1802-30-8 | Details |
| SHEN26, 10 mM in DMSO | C16H19N5O5 | 2647441-36-7 | Details |
| Senexin C, 10 mM in DMSO | C28H27N5O | 2375554-02-0 | Details |
| N 0861 | C13H17N5 | 141696-90-4 | Details |
| p38 MAP Kinase Inhibitor Ⅵ | C16H13FN2OS2 | 421578-46-3 | Details |
| NDT 9513727 | C36H35N3O4 | 439571-48-9 | Details |
| N-[1-(Aminocarbonyl)-4-[(2-chloro-1-iminoethyl)amino]butyl]benzamide | C14H19ClN4O2 | 1965308-76-2 | Details |
| Org41841 | C19H22N4O2S2 | 301847-37-0 | Details |
| NT219 | C16H14BrNO5S | 1198078-60-2 | Details |
| Paroxypropione, 10 mM in DMSO | C9H10O2 | 70-70-2 | Details |
| Ryuvidine | C15H12N2O2S | 265312-55-8 | Details |
| p38α inhibitor 4 | C14H7F6N3O | 1262406-08-5 | Details |
| PF-03049423 | C24H32N6O4 | 954138-07-9 | Details |
| SB-674042 | C24H21FN4O2S | 483313-22-0 | Details |
| SAX-187, 10 mM in DMSO | C15H13ClN4O2S2 | 554403-49-5 | Details |
| Necrostatin-7 | C16H10FN5OS2 | 351062-08-3 | Details |
| NecroX-7 | C24H29N3O3S | 1120332-55-9 | Details |
| PDD00017272 | C23H25N5O4S3 | 1945950-20-8 | Details |
| Orthanilamide, 10 mM in DMSO | C6H8N2O2S | 3306-62-5 | Details |
| PFB-FDGlu | C39H32F5NO16 | 209540-62-5 | Details |
| RO3244794 | C25H19F2NO5 | 361457-01-4 | Details |
| Mouse IgG2a kappa, Isotype Control | Details |
| mTOR inhibitor 9c | C21H22FN5O2S | 1144075-36-4 | Details |
| Notum pectinacetylesterase-1, 10 mM in DMSO | C14H14N4O2S2 | 460727-10-0 | Details |
| MK-28, 10 mM in DMSO | C24H20N4O2 | 864388-65-8 | Details |
| N2-methylguanine | C6H7N5O | 10030-78-1 | Details |
| MMPP | C17H18O3 | 1895957-18-2 | Details |
| Rovazolac | C21H19F3N2O4S | 1454288-88-0 | Details |
| Pyrintegrin, 10 mM in DMSO | C23H25N5O3S | 1228445-38-2 | Details |
| PLH2058 | 2525206-41-9 | Details |
| OUL232, 10 mM in DMSO | C10H10N4O2S | 943119-42-4 | Details |
| PK095, 10 mM in DMSO | C20H18N4O2S | 380314-37-4 | Details |
| MM41, 10 mM in DMSO | C44H66N10O6 | 1429028-96-5 | Details |
| mTOR inhibitor 9b | C21H23N5O2S | 1144075-34-2 | Details |
| SEW06622 | C21H26N2O2 | 261349-28-4 | Details |
| RE-640 | C20H16Cl2N4 | 140926-75-6 | Details |
| Protein kinase G inhibitor-1, 10 mM in DMSO | C14H18N2O2S | 354544-70-0 | Details |
| mTOR inhibitor 9a | C20H21N5O2S | 1144075-32-0 | Details |
| mTOR inhibitor 9f | C25H23N5O2S | 1144075-42-2 | Details |
| pobilukast | C26H34O5S | 107023-41-6 | Details |
| Pincainide | C16H24N2O | 83471-41-4 | Details |
| Nepasaikosaponin K | C48H80O18 | 405229-61-0 | Details |
| p53 Activator 7 | C27H32F3N4OP | 2849340-59-4 | Details |
| PF-07258669 | C25H27FN6O2 | 2755890-53-8 | Details |
| PDE5-IN-9 | C18H14N4S | 157862-84-5 | Details |
| mTOR inhibitor 13 | C24H22N6O2S | 1144075-44-4 | Details |
| PA3552-IN-1, 10 mM in DMSO | C13H8ClFN2O4 | 1008121-12-7 | Details |
| PKM2 inhibitor G, 10 mM in DMSO | C16H15NO3S | 904457-46-1 | Details |
| PF-17 | C21H28N4O5S | 2697145-21-2 | Details |
| mTOR inhibitor 9e | C22H23N5O2S | 1144075-40-0 | Details |
| mTOR inhibitor 9d | C21H23N5O3S | 1144075-38-6 | Details |
| Paltimatrectinib | C20H15F5N6 | 2353522-15-1 | Details |
| PPY A | C22H20N4O2 | 875634-01-8 | Details |
| S5A1 | C27H33N3O4.ClH | 2055882-51-2 | Details |
| SB-237376, 10 mM in DMSO | C20H25N3O5 | 179258-59-4 | Details |
| Protein kinase inhibitor 6, 10 mM in DMSO | C13H9FN2S | 348-45-8 | Details |
| RSS0680 | C52H64N10O6S3 | 2769753-48-0 | Details |
| MJN68390 | C24H28ClN3O3 | 1956368-39-0 | Details |
| PRLX-93936 HCL | C21H25ClN4O2 | 1094210-96-4 | Details |
| MMP-9-IN-7, 10 mM in DMSO | C16H15ClN4O2S2 | 333746-76-2 | Details |
| Product Total： Product Page： | ||||
| 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 | ||||